MF
MNTA

Magnetar Financial’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Magnetar Financial’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,946,428
Closed -$102M – 1030
2020
Q3 		$102M Buy
+1,946,428
New +$80.6M 1.81% 11

Magnetar Financial's MNTA Position: Q4 2020 in Review

Magnetar Financial sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,946,428 shares — an estimated $102M sold.

Magnetar Financial first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $102M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Magnetar Financial reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Magnetar Financial sold 1,946,428 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $102M.
  • Magnetar Financial first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Magnetar Financial's Momenta Pharmaceuticals, Inc. position peaked at $102M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Magnetar Financial's 13F filing for Q4 2020, filed 12 Feb 2021.